Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
基本信息
- 批准号:7860305
- 负责人:
- 金额:$ 27.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-05 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergensAllergicAllergic DiseaseAllergic inflammationAsthmaBindingBiologicalBiologyCatalogingCatalogsCell ProliferationCell physiologyCellsCharacteristicsChemotaxisClinicalCommunicable DiseasesDataDevelopmentDiseaseEquilibriumExposure toExtrinsic asthmaFutureGastrointestinal tract structureGene ExpressionGenesGeneticGoalsHealthHumanHuman VolunteersImmuneImmune responseImmunosuppressionIndividualInfectionInflammatoryInflammatory ResponseInterleukin-13Interleukin-4Interleukin-5IntestinesIrrigationKnowledgeLeukocytesLocationLungMediatingModelingMolecular TargetMusNatural Killer CellsPathogenesisPhenotypePlayPopulationProcessProductionProstaglandin D2ProstaglandinsPublic HealthRecruitment ActivityRegulationReportingRoleSignal TransductionSiteSurfaceTestingTh2 CellsTimeType - attributeWorkallergic responsebasecell typechemokinecytokinecytotoxicityfMet-Leu-Phe receptorhuman subjectimprovedin vivomacrophagemast cellmicrobialmouse modelmucosal sitenovelpathogenprostaglandin D receptorpublic health relevancereceptorrespiratoryresponse
项目摘要
DESCRIPTION (provided by applicant): Allergic immune responses are biased toward the production of type-2 cytokines. We have identified new surface markers of a small subset of human natural killer (NK) cells that produce the type-2 cytokines, IL-4 and IL-13. In addition, we have shown that these type-2 NK cells are enriched in the lungs of atopic human subjects in response to allergenic challenge. Therefore, our data suggest that these cells may contribute to the inflammatory response at sites of allergenic insult, such as mucosal surfaces of the lung and gastrointestinal tract. Our discovery of better surface markers to delineate these cells allows us to better purify them and define their functions. In this application, we propose exploratory studies to significantly improve our understanding of the biology of type-2 NK cells. Specifically, we will 1) catalog receptors on the human type-2 NK cells and test their impacts on biological responses, and 2) use our knowledge in humans to characterize the type-2 NK cells in mice and test whether they can also respond to allergenic challenge in a mouse model of asthma. The findings will fill significant gaps in our understanding of environmental signals that regulate the functions of type-2 NK cells, and establish a mouse model for studying their in vivo functions. Improved understanding of these biological parameters will allow us to establish the roles of type-2 NK cells in the pathogenesis of localized allergic responses and infections, particularly in the respiratory and intestinal tracts. Future studies, based upon our findings, will be able to identify molecular targets to manipulate the functions of type-2 NK cells to improve human health. PUBLIC HEALTH RELEVANCE: to Public Health Natural killer (NK) cells are normal white blood cells that can stimulate innate immune responses. We have recently discovered surface markers to define a small subset of NK cells that can enter the lungs of human volunteers after exposure to an allergen. These cells are unique, since they can produce soluble factors that may contribute to allergic inflammation, and therefore, we will further study these cells in humans and mice to establishing their role in human health and disease.
描述(由申请方提供):过敏性免疫应答偏向于产生2型细胞因子。我们已经确定了一小部分人自然杀伤(NK)细胞的新表面标志物,这些细胞产生2型细胞因子IL-4和IL-13。此外,我们已经表明,这些2型NK细胞富集在特应性人类受试者的肺中,以响应过敏原的挑战。因此,我们的数据表明,这些细胞可能有助于过敏性损伤部位的炎症反应,如肺和胃肠道的粘膜表面。我们发现更好的表面标记来描绘这些细胞,使我们能够更好地纯化它们并定义它们的功能。在这项应用中,我们提出了探索性研究,以显着提高我们对2型NK细胞生物学的理解。具体来说,我们将1)对人类2型NK细胞上的受体进行分类,并测试它们对生物学反应的影响,2)利用我们在人类中的知识来表征小鼠中的2型NK细胞,并测试它们是否也可以对哮喘小鼠模型中的过敏性挑战做出反应。这些发现将填补我们对调节2型NK细胞功能的环境信号的理解的重大空白,并建立研究其体内功能的小鼠模型。对这些生物学参数的进一步了解将使我们能够确定2型NK细胞在局部过敏反应和感染的发病机制中的作用,特别是在呼吸道和肠道中。基于我们的发现,未来的研究将能够确定分子靶点,以操纵2型NK细胞的功能,从而改善人类健康。自然杀伤(NK)细胞是正常的白色血细胞,可以刺激先天免疫反应。我们最近发现了表面标志物,以定义一小部分NK细胞,这些NK细胞可以在暴露于过敏原后进入人类志愿者的肺部。这些细胞是独特的,因为它们可以产生可能导致过敏性炎症的可溶性因子,因此,我们将进一步研究人类和小鼠中的这些细胞,以确定它们在人类健康和疾病中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kerry S Campbell其他文献
Kerry S Campbell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kerry S Campbell', 18)}}的其他基金
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
- 批准号:
10319570 - 财政年份:2020
- 资助金额:
$ 27.61万 - 项目类别:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
- 批准号:
10544158 - 财政年份:2020
- 资助金额:
$ 27.61万 - 项目类别:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
- 批准号:
10078249 - 财政年份:2020
- 资助金额:
$ 27.61万 - 项目类别:
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
了解惰性淋巴细胞增殖性疾病的心理社会和免疫反应
- 批准号:
9038558 - 财政年份:2016
- 资助金额:
$ 27.61万 - 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
- 批准号:
8073248 - 财政年份:2010
- 资助金额:
$ 27.61万 - 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
- 批准号:
7707072 - 财政年份:2009
- 资助金额:
$ 27.61万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
7332209 - 财政年份:2004
- 资助金额:
$ 27.61万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
6860141 - 财政年份:2004
- 资助金额:
$ 27.61万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
7168804 - 财政年份:2004
- 资助金额:
$ 27.61万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
7013613 - 财政年份:2004
- 资助金额:
$ 27.61万 - 项目类别:
相似海外基金
Measurement of serum IgE and identification of allergens in seafood allergic patients
海鲜过敏患者血清IgE测定及过敏原鉴定
- 批准号:
21K13490 - 财政年份:2021
- 资助金额:
$ 27.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of augmentation of contact allergic reactions by irritants and contact allergens
刺激物和接触性过敏原增强接触性过敏反应的机制
- 批准号:
335858052 - 财政年份:2017
- 资助金额:
$ 27.61万 - 项目类别:
Research Grants
Elucidation of conformational epitopes of peanut allergens essential for allergic reactions
阐明过敏反应所必需的花生过敏原的构象表位
- 批准号:
8970024 - 财政年份:2015
- 资助金额:
$ 27.61万 - 项目类别:
Environmental allergens affect the function of allergic inflammatory cells
环境过敏原影响过敏性炎症细胞的功能
- 批准号:
26860758 - 财政年份:2014
- 资助金额:
$ 27.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Effects of allergens on dendritic cell function in allergic asthma
过敏原对过敏性哮喘树突状细胞功能的影响
- 批准号:
nhmrc : 303161 - 财政年份:2004
- 资助金额:
$ 27.61万 - 项目类别:
NHMRC Project Grants
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8348615 - 财政年份:2001
- 资助金额:
$ 27.61万 - 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8522031 - 财政年份:2001
- 资助金额:
$ 27.61万 - 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8730013 - 财政年份:2001
- 资助金额:
$ 27.61万 - 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
- 批准号:
6137243 - 财政年份:1998
- 资助金额:
$ 27.61万 - 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
- 批准号:
2462172 - 财政年份:1998
- 资助金额:
$ 27.61万 - 项目类别: